294 related articles for article (PubMed ID: 14734741)
1. Characterization of defective CD4-CD8- T cells in murine tumors generated independent of antigen specificity.
Prins RM; Incardona F; Lau R; Lee P; Claus S; Zhang W; Black KL; Wheeler CJ
J Immunol; 2004 Feb; 172(3):1602-11. PubMed ID: 14734741
[TBL] [Abstract][Full Text] [Related]
2. Defective proximal TCR signaling inhibits CD8+ tumor-infiltrating lymphocyte lytic function.
Koneru M; Schaer D; Monu N; Ayala A; Frey AB
J Immunol; 2005 Feb; 174(4):1830-40. PubMed ID: 15699109
[TBL] [Abstract][Full Text] [Related]
3. Role of double-negative regulatory T cells in long-term cardiac xenograft survival.
Chen W; Ford MS; Young KJ; Cybulsky MI; Zhang L
J Immunol; 2003 Feb; 170(4):1846-53. PubMed ID: 12574350
[TBL] [Abstract][Full Text] [Related]
4. Enhanced tumor responses to dendritic cells in the absence of CD8-positive cells.
Ribas A; Wargo JA; Comin-Anduix B; Sanetti S; Schumacher LY; McLean C; Dissette VB; Glaspy JA; McBride WH; Butterfield LH; Economou JS
J Immunol; 2004 Apr; 172(8):4762-9. PubMed ID: 15067052
[TBL] [Abstract][Full Text] [Related]
5. The accumulation of B220+ CD4- CD8- (DN) T cells in C3H-lpr/lpr mice is not accelerated by the stimulation of CD8+ T cells or B220+ DN T cells with staphylococcal enterotoxin B and occurs independently of V beta 8+ T cells.
Giese T; Davidson WF
Int Immunol; 1995 Aug; 7(8):1213-23. PubMed ID: 7495728
[TBL] [Abstract][Full Text] [Related]
6. Absence of programmed death receptor 1 alters thymic development and enhances generation of CD4/CD8 double-negative TCR-transgenic T cells.
Blank C; Brown I; Marks R; Nishimura H; Honjo T; Gajewski TF
J Immunol; 2003 Nov; 171(9):4574-81. PubMed ID: 14568931
[TBL] [Abstract][Full Text] [Related]
7. Type 1 and type 2 CD8+ effector T cell subpopulations promote long-term tumor immunity and protection to progressively growing tumor.
Dobrzanski MJ; Reome JB; Dutton RW
J Immunol; 2000 Jan; 164(2):916-25. PubMed ID: 10623840
[TBL] [Abstract][Full Text] [Related]
8. CD8+ T cells rapidly acquire NK1.1 and NK cell-associated molecules upon stimulation in vitro and in vivo.
Assarsson E; Kambayashi T; Sandberg JK; Hong S; Taniguchi M; Van Kaer L; Ljunggren HG; Chambers BJ
J Immunol; 2000 Oct; 165(7):3673-9. PubMed ID: 11034371
[TBL] [Abstract][Full Text] [Related]
9. Divergent roles for CD4+ T cells in the priming and effector/memory phases of adoptive immunotherapy.
Hu HM; Winter H; Urba WJ; Fox BA
J Immunol; 2000 Oct; 165(8):4246-53. PubMed ID: 11035058
[TBL] [Abstract][Full Text] [Related]
10. Successful adoptive cellular immunotherapy is dependent on induction of a host immune response triggered by cytokine (IFN-gamma and granulocyte/macrophage colony-stimulating factor) producing donor tumor-infiltrating lymphocytes.
Nagoshi M; Goedegebuure PS; Burger UL; Sadanaga N; Chang MP; Eberlein TJ
J Immunol; 1998 Jan; 160(1):334-44. PubMed ID: 9551989
[TBL] [Abstract][Full Text] [Related]
11. Enrichment of lck in lipid rafts regulates colocalized fyn activation and the initiation of proximal signals through TCR alpha beta.
Filipp D; Leung BL; Zhang J; Veillette A; Julius M
J Immunol; 2004 Apr; 172(7):4266-74. PubMed ID: 15034040
[TBL] [Abstract][Full Text] [Related]
12. TCR signaling for initiation and completion of thymocyte positive selection has distinct requirements for ligand quality and presenting cell type.
Yasutomo K; Lucas B; Germain RN
J Immunol; 2000 Sep; 165(6):3015-22. PubMed ID: 10975810
[TBL] [Abstract][Full Text] [Related]
13. In CD8+ T cell-deficient lpr/lpr mice, CD4+B220+ and CD4+B220- T cells replace B220+ double-negative T cells as the predominant populations in enlarged lymph nodes.
Giese T; Davidson WF
J Immunol; 1995 May; 154(10):4986-95. PubMed ID: 7537297
[TBL] [Abstract][Full Text] [Related]
14. Fc gamma RII/III and CD2 expression mark distinct subpopulations of immature CD4-CD8- murine thymocytes: in vivo developmental kinetics and T cell receptor beta chain rearrangement status.
Rodewald HR; Awad K; Moingeon P; D'Adamio L; Rabinowitz D; Shinkai Y; Alt FW; Reinherz EL
J Exp Med; 1993 Apr; 177(4):1079-92. PubMed ID: 8096236
[TBL] [Abstract][Full Text] [Related]
15. T cells expressing receptors of different affinity for antigen ligands reveal a unique role for p59fyn in T cell development and optimal stimulation of T cells by antigen.
Utting O; Teh SJ; Teh HS
J Immunol; 1998 Jun; 160(11):5410-9. PubMed ID: 9605142
[TBL] [Abstract][Full Text] [Related]
16. CD8+ tumor-infiltrating lymphocytes are primed for Fas-mediated activation-induced cell death but are not apoptotic in situ.
Radoja S; Saio M; Frey AB
J Immunol; 2001 May; 166(10):6074-83. PubMed ID: 11342625
[TBL] [Abstract][Full Text] [Related]
17. Tumor-infiltrating lymphocytes exhibiting high ex vivo cytolytic activity fail to prevent murine melanoma tumor growth in vivo.
Prévost-Blondel A; Zimmermann C; Stemmer C; Kulmburg P; Rosenthal FM; Pircher H
J Immunol; 1998 Sep; 161(5):2187-94. PubMed ID: 9725210
[TBL] [Abstract][Full Text] [Related]
18. Pro-inflammatory self-reactive T cells are found within murine TCR-αβ(+) CD4(-) CD8(-) PD-1(+) cells.
Rodríguez-Rodríguez N; Apostolidis SA; Fitzgerald L; Meehan BS; Corbett AJ; Martín-Villa JM; McCluskey J; Tsokos GC; Crispín JC
Eur J Immunol; 2016 Jun; 46(6):1383-91. PubMed ID: 27060346
[TBL] [Abstract][Full Text] [Related]
19. p59fyn (Fyn) promotes the survival of anergic CD4-CD8- alpha beta TCR+ cells but negatively regulates their proliferative response to antigen stimulation.
Utting O; Priatel JJ; Teh SJ; Teh HS
J Immunol; 2001 Feb; 166(3):1540-6. PubMed ID: 11160194
[TBL] [Abstract][Full Text] [Related]
20. IL-2 intratumoral immunotherapy enhances CD8+ T cells that mediate destruction of tumor cells and tumor-associated vasculature: a novel mechanism for IL-2.
Jackaman C; Bundell CS; Kinnear BF; Smith AM; Filion P; van Hagen D; Robinson BW; Nelson DJ
J Immunol; 2003 Nov; 171(10):5051-63. PubMed ID: 14607902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
